Karyopharm Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.26

+0.17 (+2.79%)

As of Feb 8, 2:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +685.0% upside

Low Target $31.72

Average Target $49.14

High Target $61.64

Current Price $6.26

Current
$6.26

Target
$49.14

$31.72 $49.14 avg $61.64

Scenario Analysis

Bear Case

$31.72

406.7%

Low target

Base Case

$49.14

+685.0%

Avg target

Bull Case

$61.64

+884.7%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$42.72

-85.3% from high

52-Week Low

$31.53

+-80.1% from low

Target vs 52W High

$49.14

+15.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%